sPLA2 (human Type IIA) Western Ready Control

Product Description

Stability : 2 years
Description :
Phospholipase A2 (PLA2) catalyzes the hydrolysis of phospholipids at the sn-2 position yielding a free fatty acid and a lysophospholipid. The release of arachidonic acid from the membrane phospholipids by PLA2 is believed to be a key step in the control of eicosanoid production within the cell. Human synovial sPLA2 is a secreted 14 kDa protein which is dependent on Ca2+ for optimal activity. Human synovial sPLA2 is 79% homologous to rat platelet and murine type II sPLA2s.
Storage : -20°C

Disclaimer: the information on this website is from the internet for reference only. Please refer to the actual instructions attached to the product and the final interpretation is owned by the company.

Send inquiry online For more product information and prices

(Pharmaceutical Ingredients Manufacturer & Supplier & Exporter.)

After sending the online inquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email. —— Green Stone Swiss

Email: sales@raw-pharmaceutical-materials.com
Tel: +86 592 5365887
WhatsApp: +86 189 6515 7632
Send inquiry online: